When this site started ten years ago, its focus was on the injuries caused by polypropylene pelvic mesh.
Polypropylene or PP is a polymer that emerged from the petroleum industry. PP is THE material that has been used to make most pelvic and hernia meshes for decades.
Some patients have a terrible reaction to PP. For some, it incites an inflammatory response, hides biofilm infection, can shrink, and erode. A surgeon can unintentionally trap a nerve during placement, causing unrelenting pain.
Although it's debated, complications with PP mesh are see in upward of 30% of recipients from mild to life-altering.
PP is one of the dominant polymers used in the medical device industry alongside polyvinyl chloride (PVC) and polyethylene (PE). Because the price-to-performance ratio is very high, the market for PP is predicted to grow exponentially in the future.
We know from the many pelvic mesh trials that PP, used by manufacturers Johnson & Johnson, Boston Scientific, American Medical Systems, and C.R. Bard, is accompanied by a warning not to use polypropylene to make an implanted medical device.
The warning is contained in the Material Safety Data Sheet (MSDS) that accompanies the polymer. That warning is required by the Occupational Safety and Health Administration (OSHA) to protect workers in the manufacturing of any material.
It says specifically - “MEDICAL APPLICATION CAUTION: Do not use this Phillips Sumika Polypropylene Company material in medical applications involving permanent implantation in the human body or permanent contact with internal body fluids or tissues.”
It couldn’t be clearer.
What’s disturbing is that polypropylene mesh naturally will come into contact with both bodily fluids and tissues for the rest of that patient’s life.
Mesh makers have contended that “mesh is inert” and does not change once placed in the body, but experts at trial have shown with the help of an electron microscope, that PP continues to degrade and crack in the body.
In the upcoming March 2022 trial in Ohio trial of hernia mesh recipient, Antonio Milanesi, naming defendant Bard, the complaint lists the many complications alleged to accompany a PP hernia mesh. (Antonio Milanesi v. Bard 2:18-cv-01320, Do District of Ohio)
Mesh News Desk, September 28, 2021 What Do We Know About Polypropylene
Mesh News Desk, November 20, 2017, Do You Think it Might be the Polypropylene?
Mesh News Desk, January 6, 2017, Polypropylene Resin Not Meant for Human Implants
Mesh News Desk, A Guide to Polypropylene or PP, August 22, 2017
Mesh News Desk, Day Three: Lewis v. Ethicon ~ Polypropylene Under the Microscope
About Lawsuits -Milanesi Complaint
New Jersey Superior Court will be the venue for an upcoming number of hernia mesh trials focused on the LifeCell Strattice biologic mesh. This is the first trial of a biologic mesh made of pig skin.
Breaking News - a Verdict has just been reached for Paul Trevino who claims injuries from his Bard/Davol Ventralex mesh. Jurors decided on $4.8 Million in compensatory damages.
As the hernia mesh trial of Paul Trevino and Bard/Davol concludes its third week, MND offers a glimpse of courtroom happenings in this case, closely watched by patients, lawyers and mesh makers.